penicillamine has been researched along with tretinoin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chung, HT; Jun, CD; Kwak, HJ; Pae, HO; Park, RK; Yoo, JC | 1 |
| Fass, U; McKinney, M; Panickar, K; Personett, D | 1 |
| Kuang, H; Ma, W; Sun, M; Wu, X; Xu, C; Xu, L; Zhao, X | 1 |
1 review(s) available for penicillamine and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for penicillamine and tretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells.
Topics: Apoptosis; Bucladesine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dimethyl Sulfoxide; Glutathione; HL-60 Cells; Humans; Nitric Oxide; Nitroprusside; Nitroso Compounds; Penicillamine; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1998 |
Retinoic acid-mediated enhancement of the cholinergic/neuronal nitric oxide synthase phenotype of the medial septal SN56 clone: establishment of a nitric oxide-sensitive proapoptotic state.
Topics: Acetylcholine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Choline O-Acetyltransferase; DNA Fragmentation; Free Radicals; Gene Expression Regulation, Enzymologic; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Mice; Neuroblastoma; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxidative Stress; Penicillamine; Phenotype; Receptors, Cholinergic; RNA, Messenger; Septal Nuclei; Tretinoin; Tumor Cells, Cultured | 2000 |
Tuning the interactions between chiral plasmonic films and living cells.
Topics: Animals; Cell Adhesion; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Circular Dichroism; Gold; HeLa Cells; Humans; Membranes, Artificial; Metal Nanoparticles; Penicillamine; Stereoisomerism; Tretinoin | 2017 |